As of 2025-05-22, the Fair Value of Ascletis Pharma Inc (1672.HK) is -1.69 HKD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 7.00 HKD, the upside of Ascletis Pharma Inc is -124.16%.
With the market price of 7.00 HKD and our fair value calculation, Ascletis Pharma Inc (1672.HK) is not a good investment. Investing in 1672.HK stocks now will result in a potential loss of 124.16%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -209.20 | -199.00 | -314.84 | -144.71 | -300.94 | -233.74 |
| YoY growth | -117.92% | 4.88% | -58.21% | 54.04% | -107.95% | -45.03% |
| Market Cap (mil) | 6,745.55 |
| P/E | |
| Forward P/E |
| EPS | -0.31 |
| Avg earnings growth rate | -45.03% |
| TTM earnings | -300.94 |